neuroClues

📍 Louvain-la-Neuve, Belgium🗓 Founded 2020👥 27 employees💰 Last funded May 2024
Medical Equipment Manufacturing🌐 neuroclues.com
Website LinkedIn
In a world where Neurological disorders will affect 1 person in 3 and where the number of parkinsons patient will double in the next decade, reaching 13 million patients. Our mission is to empower clinicians with Biomarkers allowing them to identify Neurological Disorders (Parkinsons Disease, Alzheimers Disease and Multiple Sclerosis) years before visible symptoms. Our ambition with NeuroClues is to become the brains stethoscope. We are a team of seasoned MedTech entrepreneurs and doctors with as purpose to help our healthcare system cross the chasm of technology with pragmatic solutions. We work from anywhere but our base camps are in Louvain-la-Neuve, Belgium & Paris, France & NY, USA. We’re are looking to connect with individuals, companies, investors and Key Opinion Leaders that share our ambition and mission and that would be willing to partner with us in order to bring NeuroClues to the EU and US market.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
2
Frequently asked questions
Who invested in neuroClues?
neuroClues has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did neuroClues last raise funding?
The most recent investment in neuroClues recorded on gritt.io was in May 2024.
When was neuroClues founded?
neuroClues was founded in 2020.
What industry is neuroClues in?
neuroClues operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is neuroClues based?
neuroClues is headquartered in Louvain-la-Neuve, Belgium.